Noninvasive prognostic classification of ITH in HCC with multi-omics insights and therapeutic implications
Yangyang Xie, Fang Wang, Jingwei Wei, Zi-Fang Shen, Xue Song, Yali Wang, Hongjun Chen, Liye Tao, Junhao Zheng, Lanfen Lin, Ziwei Niu, Xiaojun Guan, Tianhan Zhou, Zhengao Xu, Liu Yang, Danwei Du, Haoyu Pan, Shihao Li, Wenbin Ji, Wei Zhou, Yunjun Yang, Jie Tian, Junjie Xu, Hongjie Hu, Xiao Liang
Abstract
Intratumoral heterogeneity (ITH) is a critical factor associated with treatment failure and disease relapse in hepatocellular carcinoma (HCC). However, decoding ITH in a noninvasive and comprehensive manner remains a notable challenge. In this study involving 851 patients from five centers, we developed a noninvasive prognostic classification for ITH using radiomics based on multisequence MRI, termed radiomics ITH (RITH) phenotypes. The RITH phenotypes highly correlated with prognosis and pathological ITH. In addition, through an integrated multi-omics analysis, we uncovered the molecular mechanisms underlying RITH, notably enhancing its biological interpretability. Specifically, high-RITH tumors demonstrated an enrichment of cancer-associated fibroblasts and activation of extracellular matrix remodeling. Our approach facilitates the noninvasive refined classification of ITH using radiomics and multi-omics, paving the way for tailored treatment strategies in HCC. Extracellular matrix-receptor interaction could be a potential therapeutic target in patients with high-RITH tumors. Given the routine use of radiologic imaging in oncology, our methodology ignites versatile framework for broader application to other solid tumors.